Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Brazil's Afya Posts 23% Revenue Growth In Q2 Aided By Higher Tickets In Medicine Courses

Author: Shivani Kumaresan | August 29, 2023 06:48am

Afya Ltd (NASDAQ:AFYA) reported second-quarter FY23 sales growth of 23.6% year-on-year to $143.88 million (R$712.2 million), beating the analyst consensus of $142.22 million.

Digital services revenue increased 28.2% quarter over quarter, totaling R$54.1 million. 

Adjusted EBITDA increased 21.8% Y/Y to R$268.2 million with an adjusted EBITDA margin of 37.7%, a 50 basis points contraction.

Adjusted EPS for the quarter climbed 11.8% to R$1.42.

The company held R$741.2 million in cash and equivalents as of June 30, 2023. On June 30, 2023, Net Debt, excluding the effect of IFRS 16, totaled R$2,003.6 million.

“This quarter was marked by significant increases in Net Revenue within our three segments and we are delighted to see that the most significant growth came from our Continuing Education segment with a robust intake process, and course maturation reflecting a 50% quarter-over-quarter expansion,” said management.

Outlook Reaffirmed: Afysa sees FY23 adjusted net revenue of R$2.75 billion - R$2.85 billion.

It expects adjusted EBITDA of R$1.1 billion - R$1.2 billion.

Price Action: AFYA shares closed higher by 0.83% at $14.66 on Monday.

Posted In: AFYA